Validity was evaluated at baseline via known-groups defined using first and third quartiles of patients ' Disease Activity Score @ based on C-reactive protein ( DAS@ ( CRP ) ) , Health Assessment Questionnaire-Disability Index ( HAQ-DI ) , Short Form-@ ( SF-@ ) items and PsA Quality of Life ( PsAQoL ) scores .